Riskpilot← Back to searchSign inGet full accessNordkb A/S
A/SActiveCVR 43497804Skellet 1Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20222 employees
Revenue 2024
DKK 637K
-312% vs 2023
EBITDA margin
-80.5%
+35% vs 2023
Equity ratio
-176.6%
Financial strength
Net profit 2024
DKK -415K
+38% vs 2023
| Revenue | DKK 637K | -312% |
| EBITDA | DKK -512K | +35% |
| Net profit | DKK -415K | +38% |
| Total assets | DKK 387K | -90% |
| Equity | DKK -683K | -155% |
| Employees | 2 | — |
Legal name
Nordkb A/S
CVR number
43497804
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
30. august 2022
Share capital
DKK 400.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen alene eller af bestyrelsesformanden alene.
Company purpose
Selskabets formål er at sælge medicin og medicinsk udstyr samt anden hermed beslægtet virksomhed.
Address
Skellet 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | -300 | 637 |
| Staff expenses | -492 | -1.149 |
| EBITDA | -792 | -512 |
| Depreciation & amort. | -0 | -0 |
| EBIT | -792 | -512 |
| Net financials | -64 | -18 |
| Profit before tax | -856 | -531 |
| Tax | -188 | -116 |
| Net profit | -668 | -415 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 3.837 | 387 |
| Equity | -268 | -683 |
| Long-term debt | 3.966 | 943 |
| Short-term debt | 139 | 126 |
| Total debt | 4.105 | 1.069 |
EBITDA margin
-80.5%
This company
15.8%
Market median
-609% vs market
20232024
Equity ratio
-176.6%
This company
38.2%
Market median
-562% vs market
20232024
Return on equity
-41452200.0%
This company
18.4%
Market median
-225283796% vs market
20232024
Net profit margin
-65.1%
This company
8.1%
Market median
-904% vs market
20232024
Asset turnover
1.65×
This company
1.12×
Market median
+47% vs market
20232024
Debt / equity
1.57×
This company
0.62×
Market median
-153% vs market
20232024
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Board of Directors | 2023 – 2025 | |
| Chairman | 2023 – 2025 | |
| Chairman | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nordkb A/S 
KØBN ApSBoard members of Nordkb A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kareem Obeed Abtan Al-Khulaifawi | Chairman | 0 companies |
| Ali Hussein Sahib Al-Tameemi | Board of Directors | 0 companies |
| Kareem Obeed Abtan Al-Khulaifawi | Chairman | 0 companies |
| Mohammed Kareem Obeed Al-Khulaifawi | Board of Directors | 0 companies |
| Mohammed Rafid Jasim Mohammed | Chairman | 0 companies |